Early research (Phase 1)Active Not RecruitingNCT04020809What this trial is testingNeoadjuvant Atezolizumab in Cutaneous MelanomaWho this might be right forCutaneous Melanoma The Methodist Hospital Research Institute 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT03897881What this trial is testingAn Efficacy Study of Adjuvant Treatment With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab in Participants With High-Risk Melanoma (KEYNOTE-942)Who this might be right forMelanoma ModernaTX, Inc. 267
Large-scale testing (Phase 3)Ended earlyNCT01546571What this trial is testingStudy of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma PatientsWho this might be right forMelanoma Polynoma LLC 504
Testing effectiveness (Phase 2)Looking for participantsNCT01898039What this trial is testingModified Vaccine for High Risk or Low Residual Melanoma PatientsWho this might be right forMalignant Melanoma Hadassah Medical Organization 50
Post-approval studies (Phase 4)Looking for participantsNCT03340506What this trial is testingDabrafenib and/or Trametinib Rollover StudyWho this might be right forMelanomaNon Small Cell Lung CancerSolid Tumor+2 more Novartis Pharmaceuticals 100
Large-scale testing (Phase 3)Looking for participantsNCT06488482What this trial is testingAssessment of Short Immunotherapy After Radical Surgery of High-risk Malignant MelanomaWho this might be right forHigh-risk Melanoma Uppsala University 1,792
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Early research (Phase 1)Active Not RecruitingNCT04616248What this trial is testingIn Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid TumorsWho this might be right forAnatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaPrognostic Stage IV Breast Cancer AJCC v8+10 more University of Southern California 14
Testing effectiveness (Phase 2)UnknownNCT00553618What this trial is testingAdjuvant, Combined Interleukin 2 (Proleukin) and DTIC (Dacarbazine) in High-risk Melanoma PatientsWho this might be right forMetastatic Melanoma University of Louisville 160
Not applicableLooking for participantsNCT02775461What this trial is testingPancreas Registry and High Risk RegistryWho this might be right forPancreas CancerPancreatitisChronic Pancreatitis+3 more Icahn School of Medicine at Mount Sinai 1,368
Testing effectiveness (Phase 2)Study completedNCT03554083What this trial is testingVemurafenib, Cobimetinib, Atezolizumab, and Tiragolumab in Treating Patients With High-Risk Stage III MelanomaWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Pathologic Stage III Cutaneous Melanoma AJCC v8Pathologic Stage IIIA Cutaneous Melanoma AJCC v8+3 more Mayo Clinic 64
Testing effectiveness (Phase 2)Looking for participantsNCT07115043What this trial is testingInvestigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid TumorsWho this might be right forMelanomaNon-small Cell Lung CancerSquamous Cell Carcinoma (Skin)+6 more AstraZeneca 120
Testing effectiveness (Phase 2)Looking for participantsNCT06047379What this trial is testingSafety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain MetastasisWho this might be right forDiffuse Astrocytoma, IDH-MutantGlioblastoma, IDH-wildtypeBrain Metastases, Adult+18 more Neonc Technologies, Inc. 134
Testing effectiveness (Phase 2)Study completedNCT02334735What this trial is testingA Comparison of Matured Dendritic Cells and Montanide® in Study Subjects With High Risk of Melanoma RecurrenceWho this might be right forMelanoma Nina Bhardwaj 36
Early research (Phase 1)Study completedNCT00118313What this trial is testingVaccine Therapy With or Without Imiquimod in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV MelanomaWho this might be right forMelanoma (Skin) Craig L Slingluff, Jr
Post-approval studies (Phase 4)Ended earlyNCT01856023What this trial is testingHD IL-2 + Ipilimumab in Patients With Metastatic MelanomaWho this might be right forMetastatic Melanoma Clinigen, Inc. 29
Not applicableLooking for participantsNCT05463796What this trial is testingInAdvance: Surveillance, Prevention, and Interception in a Population at Risk for CancerWho this might be right forCancer RiskCancer Predisposition SyndromeHereditary Cancer Prediction+28 more Dana-Farber Cancer Institute 5,000
Testing effectiveness (Phase 2)Ended earlyNCT03901573What this trial is testingHigh-Risk Skin Cancers With Atezolizumab Plus NT-I7Who this might be right forMelanomaMerkel Cell CarcinomaCutaneous Squamous Cell Carcinoma NeoImmuneTech 31
Testing effectiveness (Phase 2)Active Not RecruitingNCT05418972What this trial is testingClinical Trial of Neoadjuvant Relatlimab and Nivolumab in High Risk, Clinical Stage II Cutaneous MelanomaWho this might be right forStage II Melanoma Melanoma Institute Australia 20
Not applicableEnded earlyNCT03698162What this trial is testingPrecise DCE-MRI in Diagnosing Participants With Recurrent High Grade Glioma or Melanoma Brain MetastasesWho this might be right forBrain MetastasesGlioma of BrainBrain Tumor+1 more University of Southern California 15